Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul;190(2):e61-e64.
doi: 10.1111/bjh.16850. Epub 2020 Jun 8.

COVID-19-associated immune thrombocytopenia

Affiliations
Case Reports

COVID-19-associated immune thrombocytopenia

Gienke Bomhof et al. Br J Haematol. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest in carrying out this study.

Figures

Fig 1
Fig 1
The course of platelet counts of three patients (A‐C) with COVID‐19‐associated immune thrombocytopenia. Patient 3 (C) died at day 13 because of an intracerebral bleeding. IVIG, intravenous immunoglobulins (1 g/kg on two consecutive days); PC, platelet concentrate transfusion; DEX, 4 days 40 mg/day treatment with dexamethasone.

Similar articles

Cited by

References

    1. Liu Y, Sun W, Guo Y, Chen L, Zhang L, Zhao S, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020;209:1–7. - PMC - PubMed
    1. Zulfiqar AA, Lorenzo‐Villalba N, Hassler P, Andres E. Immune thrombocytopenic purpura in a patient with COVID‐19. N Engl J Med. 2020;382(18):e43. - PMC - PubMed
    1. Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381:945–55. - PubMed
    1. Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJG. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880. - PMC - PubMed
    1. Cao W, Liu X, Bai T, Fan H, Hong K, Song H, et al. High‐dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019. Open Forum Infect Dis. 2020;7:ofaa102. - PMC - PubMed